CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY

Details for Australian Patent Application No. 2003249691 (hide)

Owner AVALON PHARMACEUTICALS, INC

Inventors RICK, Jennifer, A.; EBNER, Reinhard

Pub. Number AU-A-2003249691

PCT Number PCT/US03/17592

PCT Pub. Number WO2003/104399

Priority 60/386,793 07.06.02 US

Filing date 5 June 2003

Wipo publication date 22 December 2003

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/386,793 07.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003249691

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249692-Methods for quantitative proteome analysis of glycoproteins

2003249690-DOMINANT GENE DELAYING FLOWERING